Legal Representation
Attorney
Christina Brown
USPTO Deadlines
Next Deadline
42 days remaining
NOA E-Mailed - SOU Required
Due Date
March 02, 2026
Extension Available
Until September 02, 2026
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 2, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 8, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 8, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 2, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 9, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 3, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 27, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 16, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 010
Medical testing kit comprised primarily of blood collecting tubes and bags, holder for medical sample tubes, vials and desiccant for testing blood for assessing the likelihood of patient outcomes and medical treatments; medical diagnostic apparatus for testing biological specimens, namely, molecular diagnostic tests which use molecular tools, mass spectrometry, enzyme-linked immunosorbent assays and algorithms to test biological specimens for the presence of biomarkers, to assist in assessing the likelihood of malignancy.
Class 044
Diagnostic testing services that may be ordered by health care providers to provide information for medical treatment or medical treatment decisions for patients; medical testing services for testing biological specimens for the presence of biomarkers to assist in assessing the likelihood of malignancy for diagnostic or treatment purposes; Assay development and validation for biomarkers, testing, kitting and sample storage, and diagnostic commercialization.
Classification
International Classes
010
044